Literature DB >> 1905404

An oral treatment for lead toxicity.

P S Thomas1, C Ashton.   

Abstract

Chronic lead poisoning has traditionally been treated by parenteral agents. We present a case where a comparison of ethylene diaminetetra-acetic acid was made with 2,3-dimethyl succinic acid (DMSA) which has the advantage of oral administration associated with little toxicity and appeared to be at least as efficacious.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905404      PMCID: PMC2398946          DOI: 10.1136/pgmj.67.783.63

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  Meso-dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoning.

Authors:  E Friedheim; C Crovi; C H Wakker
Journal:  J Pharm Pharmacol       Date:  1976-09       Impact factor: 3.765

2.  Chelating therapy with Na-DMS in occupational lead and mercury intoxications.

Authors:  S C Wang; K S Ting; C C Wu
Journal:  Chin Med J       Date:  1965-07

3.  [Lead poisoning treated with 2,3-dimercaptosuccinic acid].

Authors:  J F Devars du Mayne; C Prevost; B Gaudin; M Languille; M Cerf; Y Nordmann
Journal:  Presse Med       Date:  1984-10-13       Impact factor: 1.228

4.  Meso-2,3-dimercaptosuccinic acid in the diagnosis and treatment of lead poisoning.

Authors:  Y Bentur; J G Brook; R Behar; U Taitelman
Journal:  J Toxicol Clin Toxicol       Date:  1987

5.  Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations.

Authors:  J H Graziano; N J Lolacono; P Meyer
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

Review 6.  meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent.

Authors:  H V Aposhian; M M Aposhian
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

7.  Mobilization of lead by esters of meso-2,3-dimercaptosuccinic acid.

Authors:  P K Singh; M M Jones; Z Xu; G R Gale; A B Smith; L M Atkins
Journal:  J Toxicol Environ Health       Date:  1989

8.  Treatment of lead poisoning by 2,3-dimercaptosuccinic acid.

Authors:  E Friedheim; J H Graziano; D Popovac; D Dragovic; B Kaul
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

9.  Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.

Authors:  D A Cory-Slechta
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

10.  Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy.

Authors:  D A Cory-Slechta; B Weiss; C Cox
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

View more
  1 in total

1.  An oral treatment for lead toxicity.

Authors:  G W Ching; S M Rogers; R A Braithwaite; J A Vale
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.